Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: A pilot study

Shlomo Melamed*, Guy J. Ben Simon, Modi Goldenfeld, Gabriel Simon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To evaluate the safety and efficacy of Gold Micro Shunt (GMS) implantation to the supraciliary space in patients with glaucoma. Methods: A total of 38 patients with glaucoma with uncontrolled intraocular pressure (IOP) underwent implantation of the GMS in this prospective 2-center study. Main Outcome Measures: Intraocular pressure and surgical complications. Results: A total of 38 patients with glaucoma participated. The mean follow-up time was 11.7 months. The IOP decreased a mean (SD) of 9 mm Hg from 27.6 (4.7) to 18.2 (4.6) mm Hg (P < .001). Surgical success was achieved in 30 patients (79%) (IOP >5 and <22 mm Hg, with or without antiglaucoma medication). Eight patients had mild to moderate transient hyphema. Conclusions: Implantation of GMS to the supraciliary space is a safe and effective method of controlling IOP in patients with glaucoma. Use of the GMS resulted in a significant decrease in IOP. Application to Clinical Practice: The GMS could be an alternative surgical device to standard trabeculectomy.

Original languageEnglish
Pages (from-to)264-269
Number of pages6
JournalArchives of Ophthalmology
Volume127
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Dive into the research topics of 'Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: A pilot study'. Together they form a unique fingerprint.

Cite this